{"id":954764,"date":"2026-04-27T09:19:37","date_gmt":"2026-04-27T13:19:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/"},"modified":"2026-04-27T09:19:37","modified_gmt":"2026-04-27T13:19:37","slug":"avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/","title":{"rendered":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, April  27, 2026  (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm for serious, rare respiratory diseases, today announced two appointments that further strengthen its leadership team as the company advances its clinical programs and prepares for future commercialization. Adam Golden, a seasoned legal and business adviser with over three decades of experience advising biopharma companies, was appointed General Counsel and Head of Business Development. Frank Salisbury, an established leader in launching multiple FDA-approved therapies, including ESBRIET<sup>\u00ae<\/sup> (pirfenidone) for idiopathic pulmonary fibrosis (IPF), was appointed Senior Vice President, Commercial.<\/p>\n<p>\u201cWe are thrilled to welcome Adam and Frank to Avalyn at this important stage in our evolution,\u201d said Lyn Baranowski, Chief Executive Officer of Avalyn. \u201cAdam brings deep legal experience guiding life sciences companies through critical inflection points involving business development and legal strategy, all of which will be invaluable as we transition to life as a public company. Frank has a proven track record of building and leading commercial organizations for innovative respiratory treatments, including oral pirfenidone for IPF and sotatercept for PAH. Their expertise strengthens our ability to execute across corporate strategy, business operations, and commercial readiness as we advance our pipeline and position Avalyn for long-term success.\u201d<\/p>\n<p>Adam Golden has over 30 years of experience advising biopharma companies, spanning legal, business development, and corporate strategy. Prior to joining Avalyn, Mr. Golden was a Partner and Global Head of Life Sciences at Freshfields LLP, where he founded and led the build-out of an internationally recognized life sciences practice. Previously, he served as Partner and Head of the New York Corporate Practice Group at Hogan Lovells, and spent over two decades at Kaye Scholer, where he held multiple roles, including Partner and Co-Chair, Corporate Department. Over the course of his career, Mr. Golden has advised on mergers and acquisitions, strategic collaborations, corporate governance, and SEC compliance. He currently\u00a0serves\u00a0on the Board of Advisors for Life Science Cares.\u00a0Mr. Golden holds a J.D. from New York University School of Law and an A.B. in Chemistry from Princeton University.\u00a0<\/p>\n<p>Frank Salisbury brings more than 24 years of commercial leadership experience across biotechnology and large pharmaceutical companies, with a focus on rare respiratory diseases. Over the course of his career, he has played a key role in the launch and commercialization of multiple therapies. At InterMune\/Genentech, he led the U.S. launch and served as National Head of Sales for ESBRIET<sup>\u00ae<\/sup> (pirfenidone) in IPF. He also held senior commercial roles at Acceleron Pharma, where he supported the launch of WINREVAIR<sup>\u00ae<\/sup> for pulmonary arterial hypertension (PAH), as well as at Actelion, where he played a core role in the commercialization of OPSUMIT<sup>\u00ae<\/sup> (macitentan) for PAH. He joins Avalyn from PureTech Health, where he was the Senior Vice President for Commercial and Product Strategy. Mr. Salisbury earned a B.A. in International Relations and an M.B.A. from Stanford University, and was a Fulbright Scholar in Germany, where he studied HIV prevention interventions.\u00a0<\/p>\n<p>\n        <strong>About Avalyn Pharma<br \/><\/strong>Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn\u2019s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging tolerability and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone data. Avalyn\u2019s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver dual antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit\u00a0avalynpharma.com\u00a0and follow the company on\u00a0LinkedIn.<\/p>\n<p>\n        <strong>Investor Contact:<br \/><\/strong>Cassie Saitow, Avalyn Pharma Inc.<br \/>Sr. Director, IR and Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jrI-z_Vv2ZWogWx5IeGSIkYAXmR7nL97M7t3tFJKvxEVbubgdbkep5mQVTJFXZZxihHo4GcdcK1K2zZXbM_ym4n_sFyAOj7HBPQWkJucqts=\" rel=\"nofollow\" target=\"_blank\">ir@avalynpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Kat Lippincott, Deerfield Group<br \/>kat.lippincott@deerfieldgroup.com<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ShyUTn_kvV5ZWk2RWasilMqk6DguztL_4XgVGfwB86-QD06shILYlvGhE8XHW8B7l_fkd9d60qxgkJvkKsNQbMB41dIQccQZwnWv5sX-13g=\" rel=\"nofollow\" target=\"_blank\">media@avalynpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmMwNTI0MzktYTU0MC00NmU1LWFiODItMDRiOGVmZTA4Y2E4LTEyNjY2NzQtMjAyNi0wNC0yNy1lbg==\/tiny\/Avalyn-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 27, 2026 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm for serious, rare respiratory diseases, today announced two appointments that further strengthen its leadership team as the company advances its clinical programs and prepares for future commercialization. Adam Golden, a seasoned legal and business adviser with over three decades of experience advising biopharma companies, was appointed General Counsel and Head of Business Development. Frank Salisbury, an established leader in launching multiple FDA-approved therapies, including ESBRIET\u00ae (pirfenidone) for idiopathic pulmonary fibrosis (IPF), was appointed Senior Vice President, Commercial. \u201cWe are thrilled to welcome Adam and Frank to Avalyn at this important stage in our evolution,\u201d said Lyn Baranowski, Chief &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954764","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 27, 2026 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm for serious, rare respiratory diseases, today announced two appointments that further strengthen its leadership team as the company advances its clinical programs and prepares for future commercialization. Adam Golden, a seasoned legal and business adviser with over three decades of experience advising biopharma companies, was appointed General Counsel and Head of Business Development. Frank Salisbury, an established leader in launching multiple FDA-approved therapies, including ESBRIET\u00ae (pirfenidone) for idiopathic pulmonary fibrosis (IPF), was appointed Senior Vice President, Commercial. \u201cWe are thrilled to welcome Adam and Frank to Avalyn at this important stage in our evolution,\u201d said Lyn Baranowski, Chief &hellip; Continue reading &quot;Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T13:19:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury\",\"datePublished\":\"2026-04-27T13:19:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/\"},\"wordCount\":752,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/\",\"name\":\"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\",\"datePublished\":\"2026-04-27T13:19:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/","og_locale":"en_US","og_type":"article","og_title":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk","og_description":"BOSTON, April 27, 2026 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm for serious, rare respiratory diseases, today announced two appointments that further strengthen its leadership team as the company advances its clinical programs and prepares for future commercialization. Adam Golden, a seasoned legal and business adviser with over three decades of experience advising biopharma companies, was appointed General Counsel and Head of Business Development. Frank Salisbury, an established leader in launching multiple FDA-approved therapies, including ESBRIET\u00ae (pirfenidone) for idiopathic pulmonary fibrosis (IPF), was appointed Senior Vice President, Commercial. \u201cWe are thrilled to welcome Adam and Frank to Avalyn at this important stage in our evolution,\u201d said Lyn Baranowski, Chief &hellip; Continue reading \"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-27T13:19:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury","datePublished":"2026-04-27T13:19:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/"},"wordCount":752,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/","name":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=","datePublished":"2026-04-27T13:19:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwNzEzNiM3NTY2MzAwIzIyNTUxMjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954764"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954764\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}